logo True scholar network
Back to Top
Visit Website

Translational Psychiatry (TP)

Publisher :

Springer Nature

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • psychotic patients
  • psychiatric disorders
  • medical research

    • +5

e-ISSN :

2158-3188

Issue Frequency :

Monthly

Impact Factor :

5.8

Est. Year :

2011

Mobile :

4402078434977

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

translationalpsychiatry@us.nature.com, r.silao@nature.com

Journal Descriptions

Psychiatry has been held back by our limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of most commonly prescribed types of antidepressants treatment. Likewise, dopamine receptor antagonists are widely used to treat schizophrenia. Pierre Deniker and Jean Delay conducted a clinical trial at the Sainte-Anne Hospital Center in Paris in which they treated 38 psychotic patients with daily injections of chlorpromazine, a dopamine receptor antagonist, without the use of other sedating agents. The response was dramatic; treatment with chlorpromazine went beyond simple sedation with patients showing improvements in thinking and emotional behavior. That was first reported in 1952. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients that will result in better outcomes than what is provided by existing approaches. Translational Psychiatry bridges this gap by focusing on papers that directly study psychiatric disorders and bring new discovery into clinical practice. In addition to this core mission of the journal, we may consider papers from all areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging, and epidemiology, that have potential to contribute to enhance the field of translational psychiatry more broadly. To maintain balance, such papers that do not directly address our core mission will be considered on a case-by-case basis, as a matter of editorial discretion, which can also be supported by advice gained during the peer review process.


Translational Psychiatry (TP) is :

International, Peer-Reviewed, Open Access, Refereed, psychotic patients, psychiatric disorders, medical research, molecular biology, genetics, pharmacology, imaging, epidemiology , Online Monthly Journal

UGC Approved, ISSN Approved: P-ISSN , E-ISSN - 2158-3188, Established in - 2011, Impact Factor - 5.8

Provide Crossref DOI

Indexed in Scopus, WoS, DOAJ, PubMed

Not indexed in UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
WoS
Scopus Profile
DOAJ

+9 More

Publications of TP

  • dott image March, 2020

Neurocomputational mechanisms underpinning aberrant social learning in young adults with low self-esteem

Low self-esteem is a risk factor for a range of psychiatric disorders. From a cognitive perspective a negative self-image can be maintained through aberrant learning about self-worth derived...

  • dott image August, 2018

Investigating the genetic architecture of general and specific psychopathology in adolescence

Whilst associations between polygenic risk scores (PRSs) for schizophrenia and various phenotypic outcomes have been reported, an understanding of developmental pathways can only be gained b...

  • dott image Toru Suzuki
  • dott image April, 2016

Serum BDNF levels before and after the development of mood disorders: a case–control study in a population cohort

Serum levels of brain-derived neurotrophic factor (BDNF) are low in major depressive disorder (MDD), and were recently shown to decrease in chronic depression, but whether this is a trait or...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile